NCT01312831View on ClinicalTrials.gov

Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2009

Study Completion Date

December 31, 2010

Conditions
Vitamin B 12 Deficiency
Interventions
OTHER

Vitamin B12 (cyanocobalamin)

Sponsors
All Listed Sponsors
lead

Emisphere Technologies, Inc.

INDUSTRY

NCT01312831 - Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin | Biotech Hunter | Biotech Hunter